Suppr超能文献

正常受试者和库欣综合征患者的促肾上腺皮质激素释放因子(CRF)刺激试验。

Corticotropin-releasing factor (CRF) stimulation test in normal subjects and patients with Cushing's syndrome.

作者信息

Zacharieva S, Matrosov P, Stoeva I, Kirilov G

机构信息

Institute of Endocrinology and Gerontology, Medical Academy, Sofia, Bulgaria.

出版信息

Exp Clin Endocrinol. 1989 Apr;93(1):19-28. doi: 10.1055/s-0029-1210832.

Abstract

The hormonal responses to human corticotropin-releasing factor (hCRF) were investigated in 6 normal subjects, 13 patients with Cushing's disease (8 with diffuse bilateral hyperplasia and 5 with nodular hyperplasia) and one patient with Cushing's syndrome due to an adrenal adenoma. hCRF (100 micrograms i.v.) was a potent stimulant of ACTH and cortisol in normal subjects. Patients with Cushing's disease due to diffuse hyperplasia showed variable ACTH and cortisol responses to hCRF. In both normal subjects and in patients hCRF consistently stimulated serum aldosterone levels. Patients with nodular hyperplasia had extremely suppressed plasma ACTH levels and no responses of ACTH, cortisol and aldosterone to hCRF like in the patient with adrenal adenoma. Our results suggest that hCRF-stimulation test may be a useful tool for differentiating pituitary and adrenal forms of Cushing's syndrome.

摘要

对6名正常受试者、13例库欣病患者(8例双侧弥漫性增生和5例结节性增生)以及1例肾上腺腺瘤所致库欣综合征患者进行了对人促肾上腺皮质激素释放因子(hCRF)的激素反应研究。hCRF(静脉注射100微克)对正常受试者是促肾上腺皮质激素(ACTH)和皮质醇的强效刺激物。弥漫性增生所致库欣病患者对hCRF的ACTH和皮质醇反应各异。在正常受试者和患者中,hCRF均持续刺激血清醛固酮水平。结节性增生患者的血浆ACTH水平极度受抑,且对hCRF的ACTH、皮质醇和醛固酮均无反应,肾上腺腺瘤患者亦是如此。我们的结果提示,hCRF刺激试验可能是鉴别垂体性和肾上腺性库欣综合征的有用工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验